13-31758321-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_130806.5(RXFP2):c.158G>A(p.Gly53Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130806.5 missense
Scores
Clinical Significance
Conservation
Publications
- cryptorchidismInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXFP2 | NM_130806.5 | c.158G>A | p.Gly53Glu | missense_variant | Exon 2 of 18 | ENST00000298386.7 | NP_570718.1 | |
RXFP2 | NM_001166058.2 | c.158G>A | p.Gly53Glu | missense_variant | Exon 2 of 17 | NP_001159530.1 | ||
RXFP2 | XM_017020389.2 | c.158G>A | p.Gly53Glu | missense_variant | Exon 2 of 15 | XP_016875878.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251338 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727228 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74310 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.158G>A (p.G53E) alteration is located in exon 2 (coding exon 2) of the RXFP2 gene. This alteration results from a G to A substitution at nucleotide position 158, causing the glycine (G) at amino acid position 53 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at